Literature DB >> 24703841

GILZ promotes production of peripherally induced Treg cells and mediates the crosstalk between glucocorticoids and TGF-β signaling.

Oxana Bereshchenko1, Maddalena Coppo1, Stefano Bruscoli1, Michele Biagioli1, Monica Cimino1, Tiziana Frammartino1, Daniele Sorcini1, Alessandra Venanzi1, Moises Di Sante1, Carlo Riccardi2.   

Abstract

Regulatory T (Treg) cells expressing the transcription factor forkhead box P3 (FoxP3) control immune responses and prevent autoimmunity. Treatment with glucocorticoids (GCs) has been shown to increase Treg cell frequency, but the mechanisms of their action on Treg cell induction are largely unknown. Here, we report that glucocorticoid-induced leucine zipper (GILZ), a protein induced by GCs, promotes Treg cell production. In mice, GILZ overexpression causes an increase in Treg cell number, whereas GILZ deficiency results in impaired generation of peripheral Treg cells (pTreg), associated with increased spontaneous and experimental intestinal inflammation. Mechanistically, we found that GILZ is required for GCs to cooperate with TGF-β in FoxP3 induction, while it enhances TGF-β signaling by binding to and promoting Smad2 phosphorylation and activation of FoxP3 expression. Thus, our results establish an essential GILZ-mediated link between the anti-inflammatory action of GCs and the regulation of TGF-β-dependent pTreg production.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24703841     DOI: 10.1016/j.celrep.2014.03.004

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  49 in total

1.  Lack of glucocorticoid-induced leucine zipper (GILZ) deregulates B-cell survival and results in B-cell lymphocytosis in mice.

Authors:  Stefano Bruscoli; Michele Biagioli; Daniele Sorcini; Tiziana Frammartino; Monica Cimino; Paolo Sportoletti; Emanuela Mazzon; Oxana Bereshchenko; Carlo Riccardi
Journal:  Blood       Date:  2015-08-14       Impact factor: 22.113

Review 2.  Immune regulation by glucocorticoids.

Authors:  Derek W Cain; John A Cidlowski
Journal:  Nat Rev Immunol       Date:  2017-02-13       Impact factor: 53.106

Review 3.  Glucocorticoids in T cell development, differentiation and function.

Authors:  Matthew D Taves; Jonathan D Ashwell
Journal:  Nat Rev Immunol       Date:  2020-11-04       Impact factor: 53.106

Review 4.  The immunopathobiology of T cells in stress condition: a review.

Authors:  Mostafa Khedri; Azam Samei; Mahdi Fasihi-Ramandi; Ramezan Ali Taheri
Journal:  Cell Stress Chaperones       Date:  2020-04-21       Impact factor: 3.667

Review 5.  Foxp3, Regulatory T Cell, and Autoimmune Diseases.

Authors:  Jin-Hui Tao; Miao Cheng; Jiang-Ping Tang; Qin Liu; Fan Pan; Xiang-Pei Li
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

6.  Anti-inflammatory Roles of Glucocorticoids Are Mediated by Foxp3+ Regulatory T Cells via a miR-342-Dependent Mechanism.

Authors:  Dongkyun Kim; Quang Tam Nguyen; Juyeun Lee; Sung Hwan Lee; Allison Janocha; Sohee Kim; Hongnga T Le; Nina Dvorina; Kelly Weiss; Mark J Cameron; Kewal Asosingh; Serpil C Erzurum; William M Baldwin; Ju-Seog Lee; Booki Min
Journal:  Immunity       Date:  2020-07-23       Impact factor: 31.745

Review 7.  Adverse Events Following Cancer Immunotherapy: Obstacles and Opportunities.

Authors:  Kristen E Pauken; Michael Dougan; Noel R Rose; Andrew H Lichtman; Arlene H Sharpe
Journal:  Trends Immunol       Date:  2019-04-30       Impact factor: 16.687

Review 8.  Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2020-08-24       Impact factor: 3.199

Review 9.  Antenatal endogenous and exogenous glucocorticoids and their impact on immune ontogeny and long-term immunity.

Authors:  María Emilia Solano; Megan C Holmes; Paul R Mittelstadt; Karen E Chapman; Eva Tolosa
Journal:  Semin Immunopathol       Date:  2016-07-28       Impact factor: 9.623

Review 10.  Impact of Immune-Modulatory Drugs on Regulatory T Cell.

Authors:  Akiko Furukawa; Steven A Wisel; Qizhi Tang
Journal:  Transplantation       Date:  2016-11       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.